The Cancer Surveillance Program (CSP) is a rapid ascertainment population based tumor registry for Los Angeles County. All case-control studies described in the Program Project Grant application, as well as a series of separately funded analytic epidemiologic studies with total annual budgets exceeding 4 million dollars, depend on the CSP for case identification. Funds requested by this application will support the rapid ascertainment component of the CSP. After July 1, 1987, we expect the other major CSP activities (abstracting, processing, and analysis of the medical record data items which are essential to descriptive epidemiology) to be funded by the State of California. The major focus of the CSP has always been and will continue to be etiologic research. The major distinctive features of the CSP include (1) the size and diversity of the population base; (2) active as opposed to passive surveillance; (3) optimum cost-effectiveness; and (4) rapidity of case ascertainment. The latter feature is the highest priority of the CSP. Through new techniques initiated in the last year, including immediate entry of a minimal data set on each new histologically diagnosed cancer case using lap-top microcomputers available to all Field Technicians for data entry case ascertainment is now over 50% complete within one month of diagnosis and essentially 100% complete within 2 months. The active population-based rapid ascertainment feature contributes greatly to the quality of case-control studies done by this program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA017054-24
Application #
6421842
Study Section
Project Start
2001-02-01
Project End
2002-01-31
Budget Start
Budget End
Support Year
24
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Ma, Huiyan; Ursin, Giske; Xu, Xinxin et al. (2018) Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis. Breast Cancer Res 20:5
Liu, Gang; Mukherjee, Bhramar; Lee, Seunggeun et al. (2018) Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence. Am J Epidemiol 187:366-377
Ong, Jue-Sheng; Hwang, Liang-Dar; Cuellar-Partida, Gabriel et al. (2018) Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study. Int J Epidemiol 47:450-459
Harris, Holly R; Babic, Ana; Webb, Penelope M et al. (2018) Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 27:174-182
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Peres, Lauren C; Risch, Harvey; Terry, Kathryn L et al. (2018) Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol 47:460-472
Lee, Eunjung; Luo, Jianning; Schumacher, Fredrick R et al. (2018) Growth factor genes and change in mammographic density after stopping combined hormone therapy in the California Teachers Study. BMC Cancer 18:1072
Zhong, Charlie; Cockburn, Myles; Cozen, Wendy et al. (2017) Evaluating the use of friend or family controls in epidemiologic case-control studies. Cancer Epidemiol 46:9-13
Praestegaard, Camilla; Jensen, Allan; Jensen, Signe M et al. (2017) Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies. Int J Cancer 140:2422-2435
Reid, Brett M; Permuth, Jennifer B; Chen, Y Ann et al. (2017) Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci. Cancer Epidemiol Biomarkers Prev 26:116-125

Showing the most recent 10 out of 324 publications